Risks for all-cause mortality, adverse cardiovascular events, acute kidney injury, and adverse kidney events lower versus GLP-1 RA
Risks for all-cause mortality, adverse cardiovascular events, acute kidney injury, and adverse kidney events lower versus GLP-1 RA